1.
Br J Haematol
; 183(4): 537, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30022495
Assuntos
Células da Medula Óssea , Neoplasias da Medula Óssea , Carcinoma Neuroendócrino , Eritrócitos , Neutrófilos , Fagocitose , Células da Medula Óssea/metabolismo , Células da Medula Óssea/patologia , Neoplasias da Medula Óssea/metabolismo , Neoplasias da Medula Óssea/patologia , Carcinoma Neuroendócrino/metabolismo , Carcinoma Neuroendócrino/patologia , Eritrócitos/metabolismo , Eritrócitos/patologia , Feminino , Humanos , Pessoa de Meia-Idade , Neutrófilos/metabolismo , Neutrófilos/patologia
2.
Mitochondrion
; 30: 51-8, 2016 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27374853
RESUMO
We evaluated the coenzyme Q10 (CoQ) levels in patients who were diagnosed with mitochondrial oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders (n=72). Data from the 72 cases in this study revealed that 44.4% of patients showed low CoQ concentrations in either their skeletal muscle or skin fibroblasts. Our findings suggest that secondary CoQ deficiency is a common finding in OXPHOS and non-OXPHOS disorders. We hypothesize that cases of CoQ deficiency associated with OXPHOS defects could be an adaptive mechanism to maintain a balanced OXPHOS, although the mechanisms explaining these deficiencies and the pathophysiological role of secondary CoQ deficiency deserves further investigation.